Itpc Eeca Opposition, Molnupiravir (Mk 4482), (Ea202091005)
No Annotations
Alert me when there are new annotations for this document
9 similar patent oppositions
-
ABIA/GTPI opposition, Molnupiravir (MK-4482), (BR122021012627-5)
Countries: Brazil Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)
Countries: Argentina Date: 2022
-
Cancer Patient Aid Association (CPAA) opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Entrepreneurship Development Center opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Prathiba Sivasubramanian opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Keelu Lakshminarayana opposition, Molnupiravir, (202017019418)
Countries: India Date: 2021
-
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Baricitinib, (14607 / WO2009114512A1)
Countries: Viet Nam Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (AR123111A1)
Countries: Argentina Date: 2022
-
Grupo de Investigación Plebio-Universidad Nacional de Colombia-UNAL. JDR, FHT, Oscar Lizarazo. UAEM-UNAL-Colombia; Centro de Pensamiento, Medicamentos-UNAL and Others opposition, Nirmatrelvir / Ritonavir (Paxlovid), (PCT/IB2021/057281 WO/2021/250648 )
Countries: Colombia Date: 2022